Evidence map›Paper›PMID 23526966›Full record

ArticlePloS one2013

Human herpesvirus 6A partially suppresses functional properties of DC without viral replication.

Rasmus K L Gustafsson, Elin E Engdahl, Oscar Hammarfjord, Sanjaya B Adikari, Magda Lourda, Jonas Klingström, Mattias Svensson, Anna Fogdell-Hahn

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.The Journal of clinical endocrinology and metabolism · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Rasmus K L GustafssonDepartment of Clinical Neuroscience, The Multiple Sclerosis Research Group, Karolinska Institutet, Stockholm, Sweden. Rasmus.Gustafsson@ki.se
Elin E Engdahl
Oscar Hammarfjord
Sanjaya B Adikari
Magda Lourda
Jonas Klingström
Mattias Svensson
Anna Fogdell-Hahn
Karolinska Institutet · SEKarolinska University Hospital · SESwedish Institute · SEUniversity of Peradeniya · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-α signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.

Indexed as

Adaptive ImmunityCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytokinesDendritic CellsHerpesvirus 6, HumanHLA AntigensHost-Pathogen InteractionsHumansImmune ToleranceImmunity, InnateInflammation MediatorsInterferon-alphaInterleukin-4Virus ReplicationCytokinesHLA AntigensIL4 protein, humanInflammation MediatorsInterferon-alphaInterleukin-4

Identifiers

PMID23526966
PMCPMC3590851
OpenAlexW2005935881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.